Better Buy for 2018: Cara Therapeutics or Nektar Therapeutics?
These two biotechs have promising new opioid drugs. But one appears to be the better pick for investors in the new year.
Saturday, January 6, 2018
Better Buy for 2018: Cara Therapeutics or Nektar Therapeutics?
Better Buy for 2018: Cara Therapeutics or Nektar Therapeutics?
These two biotechs have promising new opioid drugs. But one appears to be the better pick for investors in the new year.
0 comments:
Post a Comment